Quarterly report (Form 10-Q)
Quest Diagnostics 10-Q for Quarter ended Jun 30, 2026
Filing excerpt
DIS volume increased by 13.1% compared to the prior year period principally driven by organic growth of 13.0%, of which approximately 9% was due to both our new relationship with Corewell Health to provide Collaborative Lab Solutions and increasing our laboratory testing at dialysis clinics owned by Fresenius Medical Care in the United States.